OK-101

Indication
Preclinical
IND
Phase 1
Phase 2
Phase 3

Neuropathic Corneal Pain (NCP)

Phase 2 Trial Completed Q2 2025

Phase 2 Trial Completed Q2 2025Phase 2

Dry Eye Disease (DED)

Phase 2 Trial Completed Q4 2023

Phase 2 Trial Completed Q4 2023Phase 2

Allergic Conjunctivitis

Preclinical

Uveitis

Preclinical

OK-201

Indication
Preclinical
IND
Phase 1
Phase 2
Phase 3

Discovery Program